Clinical trial
Double-Blind Trial Investigating the Efficacy of Different Doses of Progesterone Compared With Placebo for Treatment of Vasomotor Symptoms
NCT03202186 is registered in ClinicalTrials.gov with BHR Pharma, LLC as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double-Blind Trial Investigating the Efficacy of Different Doses of Progesterone Compared With Placebo for Treatment of Vasomotor Symptoms
- Lead sponsor
- BHR Pharma, LLC
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- August 1, 2017
- Completion date
- December 6, 2018
- Enrollment
- 55 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
menopause related conditions